Recombinant RAGE (Receptor for advanced glycation endproducts), Human ,AF
Source: Human Cytokines Catalog No. : PY2264
Recombinant RAGE (Receptor for advanced glycation endproducts), Human ,AF (PY2264)
UniProt:Q15109
Application:Cell culture,Elisa
Endotoxin level:<0.1 EU per 1 μg of the protein by the LAL method.
Gene ID:Human Cytokineshttp://www.abways.cn/showproduct.asp?cid=PY2264
数据表
-
UniProt
-
Gene ID177
-
Calculated Molecular Weight30.94 kDa
-
SDS-PAGE Molecular Weight(under reducing condition)40 kDa
-
Alternative Namesadvanced glycosylation end-product specific receptor, AGER, SCARJ1
-
ActivityTesting in process
-
StorageLyophilized protein should be stored at -20°C for 1 year. Upon reconstitution, store at 2°C to 8°C for up to 1 week. Further dilute in a buffer containing a carrier protein or stabilizer (e.g. 0.1% BSA, 10%FBS, 5%HSA or 5% trehalose solution), protei
-
Purification>98% as determined by SDS-PAGE. Ni-NTA chromatography
-
Fusion tagHis-tag at the C-terminus
-
Expression HostEscherichia coli
-
DescriptionRAGE (receptor for advanced glycation endproducts), also called AGER, is a 35 kilodalton transmembrane receptor of the immunoglobulin super family, as a signal transduction receptor which binds advanced glycation endproducts, certain members of the S1/calgranulin family of proteins, high mobility group box 1 (HMGB1), advanced oxidation protein products, and amyloid (beta-sheet fibrils). Initial studies investigating the role of RAGE in renal dysfunction focused on diabetes, neurodegenerative disorders, and inflammatory responses. However, RAGE also has roles in the pathogenesis of renal disorders that are not associated with diabetes, such as obesity-related glomerulopathy, doxorubicin-induced nephropathy, hypertensive nephropathy, lupus nephritis, renal amyloidosis, and ischemic renal injuries. RAGE represents an important factor in innate immunity against pathogens, but it also interacts with endogenous ligands, resulting in chronic inflammation. RAGE signaling has been implicated in multiple human illnesses, including atherosclerosis, arthritis, Alzheimer's disease, atherosclerosis and aging associated diseases.
-
FormulationThe protein was lyophilized from a 0.2 µm filtered solution containing 1X PBS, pH 8.0.
-
ReconstitutionIt is recommended to reconstitute the lyophilized protein in sterile H2O to a concentration not less than 100 μg/mL and incubate the stock solution for at least 20 min to ensure sufficient re-dissolved.
Applications
-
Endotoxin level<0.1 EU per 1 μg of the protein by the LAL method.
-
ApplicationCell culture,Elisa
-
Expression SequenceMAQNITARIGEPLVLKCKGAPKKPPQRLEWKLNTGRTEAWKVLSPQGGGPWDSVARVLPNGSLFLPAVGIQDEGIFRCQAMNRNGKETKSNYRVRVYQIPGKPEIVDSASELTAGVPNKVGTCVSEGSYPAGTLSWHLDGKPLVPNEKGVSVKEQTRRHPETGLFTLQSELMVTPARGGDPRPTFSCSFSPGLPRHRALRTAPIQPRVWEPVPLEEVQLVVEPEGGAVAPGGTVTLTCEVPAQPSPQIHWMKDGV



销售咨询
一键电话